Who should receive EGFR tyrosine-kinase inhibitors? Article

Overview

authors

Yu, Helena
Riely, Gregory J

publication date

October 16, 2012

published in

The Lancet. Oncology Journal

Research

keywords

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Protein Kinase Inhibitors
Quinazolines

Identity

Scopus Document Identifier

84868204421

Digital Object Identifier (DOI)

10.1016/S1470-2045(12)70434-5

PubMed ID

23078959

Additional Document Info

volume

13

issue

11